Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ki Back Chu

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Experimental Parasitology|January 12, 2025
Protection induced by recombinant vaccinia virus targeting the ROP4 of Toxoplasma gondii in miceKeon-Woong Yoon, Gi-Deok Eom, Jie Mao, et al.
Viruses|February 26, 2022
Multiple Neuraminidase Containing Influenza Virus-like Particle Vaccines Protect Mice from Avian and Human Influenza Virus InfectionHae-Ji Kang, Ki-Back Chu, Keon-Woong Yoon, et al.
Pathogens (Basel, Switzerland)|October 23, 2021
Neuraminidase in Virus-like Particles Contributes to the Protection against High Dose of Avian Influenza Virus Challenge InfectionHae-Ji Kang, Ki-Back Chu, Keon-Woong Yoon, et al.
Vaccines|October 27, 2022
Protection Induced by Vaccination with Recombinant Baculovirus and Virus-like Particles Expressing <i>Toxoplasma gondii</i> Rhoptry Protein 18Keon-Woong Yoon, Ki-Back Chu, Hae-Ji Kang, et al.
Malaria Journal|December 5, 2019
Protection induced by malaria virus-like particles containing codon-optimized AMA-1 of Plasmodium bergheiDong-Hun Lee, Ki-Back Chu, Hae-Ji Kang, et al.
ACS Applied Materials & Interfaces|October 30, 2023
Chitosan-Alginate Polymeric Nanocomposites as a Potential Oral Vaccine Carrier Against Influenza Virus InfectionHae-Ji Kang, Jiaoyang Li, Md Abdur Razzak, et al.
Pharmaceutics|July 19, 2019
Influenza Virus-Like Particles Presenting both <i>Toxoplasma gondii</i> ROP4 and ROP13 Enhance Protection against <i>T. gondii</i> InfectionHae-Ji Kang, Su-Hwa Lee, Min-Ju Kim, et al.
Antibiotics (Basel, Switzerland)|February 27, 2026
Evaluation of the Efficacy of Anthelmintic Drugs Against <i>Trichinella spiralis</i> LarvaeSoon-Ok Lee, Su In Heo, Hyeon-Woo Nam, et al.
Microbial Pathogenesis|September 10, 2020
Orally administered recombinant baculovirus vaccine elicits partial protection against avian influenza virus infection in miceSwarnendu Basak, Ki-Back Chu, Hae-Ji Kang, et al.
Plos One|April 27, 2023
Protective mucosal and systemic immunity induced by virus-like particles expressing Toxoplasma gondii cyst wall proteinGi-Deok Eom, Ki-Back Chu, Hae-Ji Kang, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Experimental Parasitology|January 12, 2025
Protection induced by recombinant vaccinia virus targeting the ROP4 of Toxoplasma gondii in miceKeon-Woong Yoon, Gi-Deok Eom, Jie Mao, et al.
Viruses|February 26, 2022
Multiple Neuraminidase Containing Influenza Virus-like Particle Vaccines Protect Mice from Avian and Human Influenza Virus InfectionHae-Ji Kang, Ki-Back Chu, Keon-Woong Yoon, et al.
Pathogens (Basel, Switzerland)|October 23, 2021
Neuraminidase in Virus-like Particles Contributes to the Protection against High Dose of Avian Influenza Virus Challenge InfectionHae-Ji Kang, Ki-Back Chu, Keon-Woong Yoon, et al.
Vaccines|October 27, 2022
Protection Induced by Vaccination with Recombinant Baculovirus and Virus-like Particles Expressing <i>Toxoplasma gondii</i> Rhoptry Protein 18Keon-Woong Yoon, Ki-Back Chu, Hae-Ji Kang, et al.
Malaria Journal|December 5, 2019
Protection induced by malaria virus-like particles containing codon-optimized AMA-1 of Plasmodium bergheiDong-Hun Lee, Ki-Back Chu, Hae-Ji Kang, et al.
ACS Applied Materials & Interfaces|October 30, 2023
Chitosan-Alginate Polymeric Nanocomposites as a Potential Oral Vaccine Carrier Against Influenza Virus InfectionHae-Ji Kang, Jiaoyang Li, Md Abdur Razzak, et al.
Pharmaceutics|July 19, 2019
Influenza Virus-Like Particles Presenting both <i>Toxoplasma gondii</i> ROP4 and ROP13 Enhance Protection against <i>T. gondii</i> InfectionHae-Ji Kang, Su-Hwa Lee, Min-Ju Kim, et al.
Antibiotics (Basel, Switzerland)|February 27, 2026
Evaluation of the Efficacy of Anthelmintic Drugs Against <i>Trichinella spiralis</i> LarvaeSoon-Ok Lee, Su In Heo, Hyeon-Woo Nam, et al.
Microbial Pathogenesis|September 10, 2020
Orally administered recombinant baculovirus vaccine elicits partial protection against avian influenza virus infection in miceSwarnendu Basak, Ki-Back Chu, Hae-Ji Kang, et al.
Plos One|April 27, 2023
Protective mucosal and systemic immunity induced by virus-like particles expressing Toxoplasma gondii cyst wall proteinGi-Deok Eom, Ki-Back Chu, Hae-Ji Kang, et al.
Pageof 9